Regulation of Mitochondrial Division by Phosphatidic Acid

磷脂酸对线粒体分裂的调节

基本信息

  • 批准号:
    10241320
  • 负责人:
  • 金额:
    $ 31.11万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2019
  • 资助国家:
    美国
  • 起止时间:
    2019-09-01 至 2023-08-31
  • 项目状态:
    已结题

项目摘要

Abstract Mitochondria are ubiquitous organelles in eukaryotic cells that play important roles in energy production, metabolism, signal transduction and cell death. These functions require precise control of mitochondrial division, and altered mitochondrial division has been linked to many neurological diseases. A key protein involved in mitochondrial division is dynamin-related protein 1 (Drp1), a mechano-chemical GTPase that constitutes the mitochondrial division machinery. Drp1 is a soluble protein recruited to mitochondria from the cytosol by Drp1 receptor proteins located on mitochondria. After being recruited, Drp1 polymerizes into higher- order oligomers. Drp1 oligomers then drive the constriction of mitochondria. In the textbook model, mitochondrial division is regulated when Drp1 is recruited and oligomerized onto mitochondria. In contrast to this current view, our recent work suggested a major mechanism by which the timing of the constriction is regulated after Drp1 is oligomerized on mitochondria. This new mechanism involves novel interactions of Drp1 with the signaling phospholipid phosphatidic acid (PA) along with saturated phospholipids in the mitochondrial outer membrane. We suggest that these lipid interactions inhibit the GTPase activity of Drp1 oligomers and thereby control the initiation of the membrane constriction. In addition, we found that a mitochondrial, PA-producing phospholipase D, MitoPLD, directly binds Drp1 and inhibits mitochondrial division. This result suggests that PA is locally created in the vicinity of the division machinery. This local PA production may ensure robust spatial regulation of Drp1. These findings led to the hypothesis that PA inhibits Drp1 and the dissociation of Drp1 from MitoPLD activates mitochondrial division. In this proposed study, we will critically test this hypothesis and further develop and adjust it in an informed way. In Aim 1, we will determine how PA changes Drp1 activity using innovative biochemical, biophysical and cellular assays. We will also analyze how the mitochondrial lipid composition changes during division using lipidomics. In Aim 2, we will decipher how Drp1-MitoPLD interactions modulate the activity of both Drp1 and MitoPLD in mitochondrial division and how Drp1-MitoPLD interactions are regulated. We will also determine how MitoPLD controls the lipid composition in mitochondria. We expect that the outcomes of this proposed study will significantly advance the important biology of phospholipids and organelle dynamics and produce critical insights into human health and diseases.
摘要

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Hiromi Sesaki其他文献

Hiromi Sesaki的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Hiromi Sesaki', 18)}}的其他基金

Structure, Turnover and Safeguard of Mitochondria
线粒体的结构、周转和保护
  • 批准号:
    10543492
  • 财政年份:
    2022
  • 资助金额:
    $ 31.11万
  • 项目类别:
Structure, Turnover and Safeguard of Mitochondria
线粒体的结构、周转和保护
  • 批准号:
    10330706
  • 财政年份:
    2022
  • 资助金额:
    $ 31.11万
  • 项目类别:
Structure, Turnover and Safeguard of Mitochondria
线粒体的结构、周转和保护
  • 批准号:
    10798515
  • 财政年份:
    2022
  • 资助金额:
    $ 31.11万
  • 项目类别:
Structure, Turnover and Safeguard of Mitochondria
线粒体的结构、周转和保护
  • 批准号:
    10581869
  • 财政年份:
    2022
  • 资助金额:
    $ 31.11万
  • 项目类别:
Regulation of Mitochondrial Division by Phosphatidic Acid
磷脂酸对线粒体分裂的调节
  • 批准号:
    10000939
  • 财政年份:
    2019
  • 资助金额:
    $ 31.11万
  • 项目类别:
Mitochondrial Quality Control by Drp1
Drp1 的线粒体质量控制
  • 批准号:
    9929888
  • 财政年份:
    2018
  • 资助金额:
    $ 31.11万
  • 项目类别:
Mitochondrial Quality Control by Drp1
Drp1 的线粒体质量控制
  • 批准号:
    9889969
  • 财政年份:
    2018
  • 资助金额:
    $ 31.11万
  • 项目类别:
Introducing Mitochondrial Stasis in Neurons
在神经元中引入线粒体停滞
  • 批准号:
    8568892
  • 财政年份:
    2013
  • 资助金额:
    $ 31.11万
  • 项目类别:
Mitochondrial Fusion and Division
线粒体融合与分裂
  • 批准号:
    8270512
  • 财政年份:
    2010
  • 资助金额:
    $ 31.11万
  • 项目类别:
Mitochondrial Fusion and Division
线粒体融合与分裂
  • 批准号:
    7985893
  • 财政年份:
    2010
  • 资助金额:
    $ 31.11万
  • 项目类别:

相似国自然基金

新型F-18标记香豆素衍生物PET探针的研制及靶向Alzheimer's Disease 斑块显像研究
  • 批准号:
    81000622
  • 批准年份:
    2010
  • 资助金额:
    20.0 万元
  • 项目类别:
    青年科学基金项目
阿尔茨海默病(Alzheimer's disease,AD)动物模型构建的分子机理研究
  • 批准号:
    31060293
  • 批准年份:
    2010
  • 资助金额:
    26.0 万元
  • 项目类别:
    地区科学基金项目
跨膜转运蛋白21(TMP21)对引起阿尔茨海默病(Alzheimer'S Disease)的γ分泌酶的作用研究
  • 批准号:
    30960334
  • 批准年份:
    2009
  • 资助金额:
    22.0 万元
  • 项目类别:
    地区科学基金项目

相似海外基金

Pathophysiological mechanisms of hypoperfusion in mouse models of Alzheimer?s disease and small vessel disease
阿尔茨海默病和小血管疾病小鼠模型低灌注的病理生理机制
  • 批准号:
    10657993
  • 财政年份:
    2023
  • 资助金额:
    $ 31.11万
  • 项目类别:
Social Connectedness and Communication in Parents with Huntington''s Disease and their Offspring: Associations with Psychological and Disease Progression
患有亨廷顿病的父母及其后代的社会联系和沟通:与心理和疾病进展的关联
  • 批准号:
    10381163
  • 财政年份:
    2022
  • 资助金额:
    $ 31.11万
  • 项目类别:
The Role of Menopause-Driven DNA Damage and Epigenetic Dysregulation in Alzheimer s Disease
更年期驱动的 DNA 损伤和表观遗传失调在阿尔茨海默病中的作用
  • 批准号:
    10531959
  • 财政年份:
    2022
  • 资助金额:
    $ 31.11万
  • 项目类别:
The Role of Menopause-Driven DNA Damage and Epigenetic Dysregulation in Alzheimer s Disease
更年期驱动的 DNA 损伤和表观遗传失调在阿尔茨海默病中的作用
  • 批准号:
    10700991
  • 财政年份:
    2022
  • 资助金额:
    $ 31.11万
  • 项目类别:
Interneurons as early drivers of Huntington´s disease progression
中间神经元是亨廷顿病进展的早期驱动因素
  • 批准号:
    10518582
  • 财政年份:
    2022
  • 资助金额:
    $ 31.11万
  • 项目类别:
Interneurons as Early Drivers of Huntington´s Disease Progression
中间神经元是亨廷顿病进展的早期驱动因素
  • 批准号:
    10672973
  • 财政年份:
    2022
  • 资助金额:
    $ 31.11万
  • 项目类别:
Social Connectedness and Communication in Parents with Huntington''s Disease and their Offspring: Associations with Psychological and Disease Progression
患有亨廷顿病的父母及其后代的社会联系和沟通:与心理和疾病进展的关联
  • 批准号:
    10585925
  • 财政年份:
    2022
  • 资助金额:
    $ 31.11万
  • 项目类别:
Oligodendrocyte heterogeneity in Alzheimer' s disease
阿尔茨海默病中的少突胶质细胞异质性
  • 批准号:
    10180000
  • 财政年份:
    2021
  • 资助金额:
    $ 31.11万
  • 项目类别:
Serum proteome analysis of Alzheimer´s disease in a population-based longitudinal cohort study - the AGES Reykjavik study
基于人群的纵向队列研究中阿尔茨海默病的血清蛋白质组分析 - AGES 雷克雅未克研究
  • 批准号:
    10049426
  • 财政年份:
    2021
  • 资助金额:
    $ 31.11万
  • 项目类别:
Repurposing drugs for Alzheimer´s disease using a reverse translational approach
使用逆翻译方法重新利用治疗阿尔茨海默病的药物
  • 批准号:
    10295809
  • 财政年份:
    2021
  • 资助金额:
    $ 31.11万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了